Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts is a paper indexed in PICO Portal from OpenAlex.
How many citations does Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts have?
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts has 230 citations in the OpenAlex counts PICO Portal stores.
When was Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts published?
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts has 2018 year in the PICO Portal index.
What is the open-access status of Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts?
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts has hybrid oa status in the PICO Portal index.
What is the DOI of Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts?
The DOI for Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts is on the source record.
What is the PMID of Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts?
The PMID for Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts is on the source record.
What is the OpenAlex record for Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts?
The OpenAlex for Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts is on the source record.